346 studies found for:    HSV
Show Display Options
Rank Status Study
1 Terminated A Study of HSV Testing Among Pregnant Women
Conditions: Herpes Simplex;   Pregnancy
Interventions: Behavioral: Safer-sex counseling;   Procedure: Type specific serologic HSV testing
2 Completed Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141;   Biological: Herpes simplex virus containing gD-Alum
3 Recruiting Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection
Conditions: Genital Herpes;   Herpes Simplex Virus;   Herpes Simplex Virus Vaccines;   HSV Vaccines;   Herpesvirus Vaccines
Intervention: Biological: HSV529
4 Completed Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine GSK208141 - non-MPL-containing adjuvant;   Biological: Herpes simplex candidate vaccine GSK208141- MPL-containing adjuvant
5 Completed Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine- adjuvanted GSK208141;   Biological: Placebo injection
6 Recruiting Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine
Condition: Genital Herpes Simplex Type 2
Interventions: Biological: Matrix-M2 Adjuvant;   Biological: GEN-003 Vaccine;   Drug: Placebo
7 Completed Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects
Condition: Prophylaxis for Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine- adjuvanted GSK 208141;   Biological: Placebo
8 Completed HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.
Conditions: HIV Infection;   Herpes Simplex;   Sexually Transmitted Diseases
Interventions: Drug: valacyclovir;   Drug: matching placebo
9 Recruiting Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture
Condition: Herpes Simplex Virus
Intervention: Device: Genexpert assay
10 Recruiting Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.
Condition: Malignant Pleural Mesothelioma
Intervention: Biological: HSV1716 Intra-pleural delivery
11 Recruiting HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
Condition: Non-CNS Solid Tumors
Intervention: Biological: HSV1716
12 Not yet recruiting A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)
Condition: Herpes Simplex Virus
Interventions: Drug: Novel Antiviral Drug;   Drug: Placebo
13 Recruiting Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
Conditions: Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma
Interventions: Biological: oncolytic HSV-1716;   Drug: dexamethasone;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
14 Completed
Has Results
HerpeVac Trial for Young Women
Condition: Herpes Simplex Infection
Interventions: Biological: HSV vaccine or SB208141, GSK Biologicals' glycoprotein D (gD)-Alum/3-deacylated form of Monophosphoryl Lipid A (MPL) candidate genital herpes vaccine;   Biological: Havrix™, GlaxoSmithKline (GSK) Biologicals' licensed Hepatitis A vaccine
15 Completed Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon
Conditions: HIV-1 and HSV-2 Coinfection;   HIV Infections
Intervention: Drug: Acyclovir
16 Completed Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-Positive Adults
Condition: Prophylaxis Herpes Simplex
Intervention: Biological: Herpes simplex candidate (gD) vaccine GSK208141
17 Active, not recruiting Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daily Valacyclovir in the Reduction of HSV-2 Recurrence and Viral Shedding
Conditions: HSV-2;   HIV;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
18 Completed Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine
Condition: Herpes Simplex
Intervention: Biological: GSK208141 vaccine
19 Completed
Has Results
Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection
Condition: Oral Herpes Simplex
Interventions: Drug: BTL TML HSV;   Drug: Matching placebo
20 Completed
Has Results
Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth
Condition: Herpes Simplex
Interventions: Drug: Acyclovir;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years